Study shows stimulant drug may help women cope with post-menopausal memory lapses

by Lee-Ann Donegan

Menopausal women have long reported experiencing hot flashes, mood swings, night sweats and memory lapses, too.

A new study from researchers in the Perelman School of Medicine at the University of Pennsylvania shows preliminary evidence that the psychostimulant drug lisdexamfetamine (LDX) can aid post- by improving attention and concentration, organization, and recall. The findings will be presented by C. Neil Epperson, MD, director of the Penn Center for Women's Behavioral Wellness, on Tuesday during the American Psychiatric Association annual meeting at the Jacob K. Javits Convention Center in New York City.

Dr. Epperson's study enrolled 30 between the ages of 48 and 60 who had experienced a diminished ability to focus and multi-task in their early post-menopausal years. The cohort was made up of successful women –none of whom were more than five years post-menopause.

The double-blind, placebo-controlled crossover study gave participants a four week regimen of LDX (which has been approved by the FDA for the of ADHD) as well as four weeks of placebo to assess the drug's effectiveness in reducing subjective, new-onset executive function difficulties, and improving performance on verbal recall, working memory and attention tasks.

A subset of women also underwent brain imaging, functional MRI and proton magnetic resonance spectroscopy to assess brain activation and dorsal lateral prefrontal cortex neurochemistry.

The women were then asked to report their level of executive function across five domains: Organization and motivation for work; concentration and attention; alertness, effort and processing speed and managing affective interference, the tendency to overly focus on the emotion of a message; and working memory and recall.

Preliminary data show that all executive function domains, except managing affective interference, showed a significant reduction in severity of symptoms during active LDX treatment versus treatment with placebo. In one domain, organization and motivation for work, the severity of reported impairment predicted the degree of response to LDX treatment such that women with greater severity of symptoms in this domain found the greatest improvement with LDX treatment.

"While some individuals experienced no improvement with LDX, we were heartened by these findings and hope to examine the genetic profile of our participants in the near future to determine whether there are predictors regarding who is is most likely to experience improvement with this kind of treatment," says Epperson.

"We know that estradiol treatment is helpful in only a subset of the population of menopausal women with cognitive and mood complaints and for many women estradiol treatment is not an option due to their medical history. It is crucial that we identify treatment options for those women who experience significant changes in cognition during this transition, whether it occurs naturally or is induced by surgery or chemotherapies."

She suggests that additional research will be necessary to determine if pyschostimulants that work for very different, but related, conditions, might be an option for these menopausal women with issues.

More information: Epperson will present the abstract "Mid-life Onset of ADHD-like Cognitive Impairments in Menopausal Women," on Tuesday, May 6th in Room 1E09, Level 1 location from 2 p.m. to 5 p.m.

add to favorites email to friend print save as pdf

Related Stories

Yoga may improve menopausal quality of life

Mar 06, 2014

(HealthDay)—Yoga may improve menopause-related quality of life (QOL) in women with vasomotor symptoms, according to research published in the March issue of the American Journal of Obstetrics & Gynecology.

Recommended for you

Evidence-based recs issued for systemic care in psoriasis

9 hours ago

(HealthDay)—For appropriately selected patients with psoriasis, combining biologics with other systemic treatments, including phototherapy, oral medications, or other biologic, may result in greater efficacy ...

Bacteria in caramel apples kills at least four in US

10 hours ago

A listeria outbreak believed to originate from commercially packaged caramel apples has killed at least four people in the United States and sickened 28 people since November, officials said Friday.

Steroid-based treatment may answer needs of pediatric EoE patients

10 hours ago

A new formulation of oral budesonide suspension, a steroid-based treatment, is safe and effective in treating pediatric patients with eosinophilic esophagitis (EoE), according to a new study in Clinical Gastroenterology and Hepatology, the official clinical practice journal ...

Discovery of genes that predispose a severe form of COPD

13 hours ago

A study by Ramcés Falfán-Valencia, researcher at the National Institute of Respiratory Diseases (INER), found that the mestizo Mexican population has a number of variations in certain genes that predispose ...

On the environmental trail of food pathogens

14 hours ago

Tracking one of the deadliest food contamination organisms through produce farms and natural environments alike, Cornell microbiologists are showing how to use big datasets to predict where the next outbreak could start.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.